Propofol promotes spinal cord injury repair by bone marrow mesenchymal stem cell transplantation.

Abstract

Propofol is a neuroprotective anesthetic. Whether propofol can promote spinal cord injury repair by bone marrow mesenchymal stem cells remains poorly understood. We used rats to investigate spinal cord injury repair using bone marrow mesenchymal stem cell transplantation combined with propofol administration via the tail vein. Rat spinal cord injury was clearly alleviated; a large number of newborn non-myelinated and myelinated nerve fibers appeared in the spinal cord, the numbers of CM-Dil-labeled bone marrow mesenchymal stem cells and fluorogold-labeled nerve fibers were increased and hindlimb motor function of spinal cord-injured rats was markedly improved. These improvements were more prominent in rats subjected to bone marrow mesenchymal cell transplantation combined with propofol administration than in rats receiving monotherapy. These results indicate that propofol can enhance the therapeutic effects of bone marrow mesenchymal stem cell transplantation on spinal cord injury in rats.

• Authors: Ya-Jing Zhou, Jian-Min Liu, Shu-Ming Wei, Yun-Hao Zhang, Zhen-Hua Qu, Shu-Bo Chen
• Journal: Neural regeneration research (Neural Regen Res) Vol. 10 Issue 8 Pg. 1305-11 (Aug 2015) ISSN: 1673-5374 [Print] India
• PMID: 26487860 (Publication Type: Journal Article)